Form 4: Pediatrix Medical Group Director John M. Starcher Jr. Reports Acquisition and Disposal of Common Stock

Director John M. Starcher Jr. reports changes in beneficial ownership of Pediatrix Medical Group, Inc. common stock, including acquisition of shares and disposal of shares.

Summary

• On May 8, 2025, John M. Starcher Jr., a director of Pediatrix Medical Group, Inc., reported acquiring 11,427 shares of common stock.
• These shares were acquired at a price of $0.
• Starcher also reported disposing of shares.
• Following these transactions, Starcher beneficially owns 66,064 shares of common stock.
• The acquisition of shares was related to a restricted stock grant under the company's Amended and Restated 2008 Incentive Compensation Plan, which will vest on May 8, 2026.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The acquisition of shares could be seen as slightly positive, but it's a routine disclosure.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of restricted shares on May 8, 2026, suggests a continued relationship between the director and the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Stakeholder Impact

• The change in beneficial ownership may be of interest to shareholders.

Key Dates

Keywords

beneficial ownership, Form 4, Pediatrix Medical Group, director, stock acquisition, stock disposal, restricted stock, John M. Starcher Jr., MD